arrow
N

Nicola Relitti

IRBM SpA
H指数:15
被引数:745

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability
2022-08-0120
PRE
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy
2022-05-018
OAAI
Design and Synthesis of Oligopeptidic Parvulin Inhibitors
2022-04-262
OA
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
2021-07-1242
OAAI
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents
2021-04-2315
OA
Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity
2021-04-016
PREAI
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
2021-02-0132
PREAI
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation
2020-09-2934
OAAI
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems
2019-12-0114
OAAI
Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents
2019-10-2930
PREAI